United Therapeutics CorporationUTHRNASDAQ
Loading
ROE TrendStable
Percentile Rank50
3Y CAGR+7.4%
5Y CAGR+4.4%
Year-over-Year Change
Return on equity
3Y CAGR
+7.4%/yr
vs -8.0%/yr prior
5Y CAGR
+4.4%/yr
Recent acceleration
Acceleration
+15.4pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
4 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 18.81% | +1.4% |
| 2024 | 18.55% | +12.7% |
| 2023 | 16.46% | +8.5% |
| 2022 | 15.16% | +26.2% |
| 2021 | 12.02% | -20.7% |
| 2020 | 15.16% | +503.4% |
| 2019 | -3.76% | -117.8% |
| 2018 | 21.13% | +6.3% |
| 2017 | 19.88% | -48.1% |
| 2016 | 38.33% | - |